Dr. Brendon L Neuen

Associate Professor Brendon Neuen is Program Lead (Renal and Metabolic) at The George Institute for Global Health, a Staff Specialist Nephrologist, and Director of Kidney Trials at Royal North Shore Hospital. He is the Founding Secretariat (Co-Chair) of the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists’ (SMART-C) Consortium (https://www.smart-c.net/) and leads multiple global, late-phase drug registration trials evaluating therapies to prevent kidney failure and cardiovascular disease. His research has informed more than 30 international clinical practice guidelines, and he is actively involved in the development of national and international standards, including for KDIGO and the American Society of Nephrology. A/Prof Neuen has authored over 150 peer-reviewed publications, including works in The Lancet, JAMA, and Nature Medicine. He serves on the editorial boards for flagship journals of the American Society of Nephrology, European Renal Association, and the American Diabetes Association. A/Prof Neuen studied medicine at James Cook University (First Class Honours, Academic Medal), holds a Masters in Global Health from the University of Oxford (Clarendon Scholar), a PhD from UNSW, and completed his Postdoctoral Fellowship at Harvard Medical School. A Fellow of both the Royal Australasian College of Physicians and the American Society of Nephrology, his work is supported by the NHMRC, Ramaciotti Foundation and philanthropic sources, and has been recognized through awards including the Royal Society of New South Wales Ida Browne Medal and the American Heart Association’s Paul Dudley White International Scholar Award.

Board certifications